Atrial Fibrillation
-
Genes and age studied as markers for higher death rate in those with atrial fibrillation
Younger patients with atrial fibrillation who had rare genetic variants associated with inherited cardiomyopathy and arrythmia syndromes were associated with a significantly higher rate of death than those without the variants, a Vanderbilt-led study has shown. Read MoreJun 8, 2022
-
Study finds pixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention, reduced bleeding complications
There is strong evidence that the medication apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stoke prevention in patients with atrial fibrillation (AF), with both reduced rates of severe bleeding complications as well as strokes, according to study published Dec. 21 in JAMA. Read MoreDec 21, 2021
-
VUMC joins research network to fight atrial fibrillation
Vanderbilt University Medical Center (VUMC) has been selected by the American Heart Association (AHA) to participate in a six-member research network to advance treatment and prevention of atrial fibrillation (AFib), an irregular heart rate that increases the risk of stroke and other heart-related complications. Read MoreJun 14, 2018
-
Multiple options help atrial fibrillation patients
Since launching its program offering patients with non-valvular atrial fibrillation (AF) an alternative treatment to reduce their risk of stroke and avoiding long-term use of blood thinners, the Vanderbilt Heart and Vascular Institute (VHVI) has consistently ranked among the top centers in the country for the implantation of left atrial appendage closure (LAAC) devices. Read MoreFeb 22, 2018
-
VUMC testing device to reduce stroke risk in arrhythmia patients
Vanderbilt University Medical Center (VUMC) is the first in the state to enroll patients in a clinical trial testing the effectiveness of the newest implantable device used to reduce stroke risk in patients with non-valvular atrial fibrillation (AF), the most common form of arrhythmia. Read MoreFeb 9, 2017
-
Device helps curb atrial fibrillation patients’ stroke risk
Peggy Tubb doesn’t recall her exact reaction when she was told she could stop taking blood thinners to treat atrial fibrillation (AF), but the news changed her life. Read MoreAug 25, 2016
-
Risk of death in the ICU
The irregular heart rhythm atrial fibrillation increases the risk of death in patients in the intensive care unit. Read MoreOct 15, 2015
-
Vanderbilt Heart offers alternative to blood thinners for atrial fibrillation
Vanderbilt Heart and Vascular Institute now offers patients with atrial fibrillation (AF) an alternative treatment to reduce their risk of stroke, potentially avoiding the long-term use of blood thinners such as warfarin. Read MoreJun 17, 2015
-
Does fish oil help prevent A-fib?
Growing evidence suggests that fish oil, thought to directly prevent inflammation, oxidative stress and heart disease, may have limited clinical utility. Read MoreJan 9, 2015
-
Atrial disease and hypertension links
New findings suggest that misfolded proteins accumulate in the heart atria, particularly in patients with hypertension, and may contribute to atrial heart disease. Read MoreDec 18, 2014
-
Normalizing calcium flux to treat atrial fibrillation
A particular anti-arrhythmia drug provides a targeted treatment for certain forms of atrial fibrillation. Read MoreMay 12, 2014
-
New technique helps spot atrial fibrillation genetic variations
A technique called whole-exome sequencing (WES) has been used for the first time at Vanderbilt University to identify new genetic variations associated with a common disease — a heart rhythm abnormality called atrial fibrillation (AF). Read MoreMay 8, 2014
-
Keeping the beat after heart surgery
Variation in the gene for the beta-1 adrenergic receptor increases the risk that a patient will have an abnormal heart rhythm after cardiac surgery. Read MoreFeb 10, 2014
-
Pioneering cardiothoracic surgeon to speak Nov. 22
James L. Cox UPDATE: Due to unforeseen circumstances, the Rollin A. Daniel Jr. M.D. Lecture scheduled for Nov. 22 has been canceled. It will be rescheduled for a later date. Pioneering cardiothoracic surgeon James L. Cox will speak on the history and future of atrial fibrillation therapies at 7 a.m. Friday,… Read MoreNov 5, 2013
-
Rhythm response tied to gene variant
A genetic variant that increases risk for atrial fibrillation also impacts the response to a common therapy for the heart rhythm disorder. Read MoreJun 21, 2013
-
Novel gene linked to familial atrial fibrillation
A rare genetic variant that occurs more commonly in families of patients with atrial fibrillation (AF) may be a key to better understanding this common and potentially life threatening condition, Vanderbilt University researchers reported this week. Read MoreDec 13, 2012
-
Common genetic signals for atrial fibrillation decoded
An international study co-led by researchers at Vanderbilt University has uncovered six new “susceptibility loci,” chromosomal regions located in or near genes that may play a role in atrial fibrillation, the most commonly diagnosed heart condition. Read MoreJun 8, 2012
-
Study points to personal treatment for atrial fibrillation
Individuals with atrial fibrillation who have a particular genetic variant respond better to rate control therapy. Read MoreDec 6, 2011